• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Healthcare Triangle Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

    9/15/25 5:00:58 PM ET
    $HCTI
    EDP Services
    Technology
    Get the next $HCTI alert in real time by email
    false 0001839285 0001839285 2025-09-15 2025-09-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) September 15, 2025

     

    HEALTHCARE TRIANGLE, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-40903   84-3559776
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    7901 Stoneridge Dr., Suite 220 Pleasanton, CA 94588

    (Address of principal executive offices)

     

    (925)-270-4812

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.00001 per share   HCTI   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    NASDAQ Notice Regaining Compliance; No Further Action Required

     

    On September 15, 2025, Healthcare Triangle, Inc. (the “Company”) received a letter from the Nasdaq Stock Market (“Nasdaq”) indicating that the Company had previously failed to comply with Nasdaq Listing Rule 5635(a)(1), which requires shareholder approval prior to the issuance of common stock representing 20% or more of the pre-transaction outstanding voting power or shares in connection with an acquisition. Nasdaq’s determination was based on the Company’s Form 8-K filed June 23, 2025, which disclosed that the Company agreed to issue approximately 345,622,120 shares of common stock (prior to adjustment for the Company’s subsequent 1-for-249 reverse stock split) as consideration for the acquisition of Niyama Healthcare, Inc. and Ezovion Solutions Private Limited.

     

    Nasdaq’s letter stated that the issuance would have represented approximately 33.8% of the Company’s pre-transaction outstanding common stock and therefore required shareholder approval under Listing Rule 5635(a)(1). Because such approval had not been obtained at that time, the Company was not in compliance with the Rule.

     

    On August 28, 2025, the Company amended the acquisition agreement to condition the issuance of the share consideration (as adjusted for the reverse stock split) upon shareholder approval. Based on this amendment, Nasdaq determined that the Company has regained compliance with Listing Rule 5635(a)(1). No further action is required by the Company at this time, and the Company remains in compliance with all applicable Nasdaq continued listing requirements. 

     

    Item 7.01. Regulation FD Disclosure

     

    The Company is furnishing presentation materials (the “Investor Presentation”) that management intends to use, possibly with modifications, in one or more meetings from time to time with current and potential investors. The Investor Presentation includes an update on the Company’s current operations and projects, as well as information relating to the Company’s strategic plans, goals, growth initiatives and outlook, and forecasts for future performance and industry development.

     

    The foregoing description of the Investor Presentation does not purport to be complete and is qualified in its entirety by reference to the complete text of the Investor Presentation attached as Exhibit 99.1 to this Current Report on Form 8-K.

     

    The information contained in the Investor Presentation is summary information that should be considered in the context of the Company’s filings with the Securities and Exchange Commission and other public announcements the Company may make by press release or otherwise from time to time. The Investor Presentation speaks as of the date of this report. While the Company may elect to update the Investor Presentation in the future to reflect events and circumstances occurring or existing after the date of this report, the Company specifically disclaims any obligation to do so.

     

    By furnishing the portions of this Current Report on Form 8-K that are disclosed under this Item 7.01 and the Investor Presentation that is an exhibit hereto, the Company makes no admission as to the materiality of any information included under this Item 7.01, including without limitation the Investor Presentation. The Investor Presentation contains forward-looking statements. See Page 2 of the Investor Presentation for a discussion of certain forward-looking statements that are included therein and the risks and uncertainties related thereto. The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

     

    1

     

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit No.   Description
    99.1   Investor Presentation
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    Forward-Looking Statements

     

    Certain statements made in this Current Report on Form 8-K are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the “safe harbor” provisions under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this Current Report on Form 8-K are forward-looking statements. When used in this Current Report on Form 8-K, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations of these words or similar expressions (or the negative versions of such words or expressions), as they relate to the Company or its management team, are intended to identify forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this Current Report on Form 8-K, including the Company’s ability to successfully appeal the Nasdaq staff’s delisting determination and the Company’s ability to have an application to trade on the OTCQB approved timely to commence trading if its common shares are delisted from Nasdaq. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” section of the Company’s Annual Report on Form 10-K filed on March 31, 2025, and other reports and registration statements of the Company filed, or to be filed, with the Securities and Exchange Commission, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. All subsequent written or oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by this paragraph. The Company undertakes no obligation to update or revise any forward-looking statements for revisions or changes after the date of this Current Report on Form 8-K, except as required by law.

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      Healthcare Triangle, Inc.
         
    Dated: September 15, 2025 By: /s/ David Ayanoglou
        David Ayanoglou
        Chief Financial Officer

     

     

    3

     

    Get the next $HCTI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCTI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HCTI
    SEC Filings

    View All

    SEC Form PRE 14A filed by Healthcare Triangle Inc.

    PRE 14A - Healthcare Triangle, Inc. (0001839285) (Filer)

    9/30/25 4:20:50 PM ET
    $HCTI
    EDP Services
    Technology

    Healthcare Triangle Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Healthcare Triangle, Inc. (0001839285) (Filer)

    9/15/25 5:00:58 PM ET
    $HCTI
    EDP Services
    Technology

    Amendment: Healthcare Triangle Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Entry into a Material Definitive Agreement

    8-K/A - Healthcare Triangle, Inc. (0001839285) (Filer)

    8/29/25 5:52:41 PM ET
    $HCTI
    EDP Services
    Technology

    $HCTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Business Head Kannappan Lakshmanan acquired 304,180 shares, increasing direct ownership by 1,521% to 324,180 units (SEC Form 4)

    4 - Healthcare Triangle, Inc. (0001839285) (Issuer)

    4/2/25 5:13:23 PM ET
    $HCTI
    EDP Services
    Technology

    Head of M&A Kizhakevilayil Shibu acquired 34,129 shares, increasing direct ownership by 171% to 54,129 units (SEC Form 4)

    4 - Healthcare Triangle, Inc. (0001839285) (Issuer)

    4/2/25 5:12:34 PM ET
    $HCTI
    EDP Services
    Technology

    Chief Financial Officer Ramachandran Thyagarajan acquired 14,627 shares, increasing direct ownership by 98% to 29,627 units (SEC Form 4)

    4 - Healthcare Triangle, Inc. (0001839285) (Issuer)

    4/2/25 5:11:47 PM ET
    $HCTI
    EDP Services
    Technology

    $HCTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks

    Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 29, 2025 /PRNewswire/ -- Equity Insider News Commentary – There's a lot of big voices pushing for the AI revolution to make its mark, including a new plan from the U.S. Department of Commerce to address slow-to-adopt sectors like healthcare. The comes as part of US President Trump's paper, titled Winning the Race: AMERICA'S AI ACTION PLAN, which encourages setting up regulatory sandboxes, or regulation-free environments where AI can be tested in real world scenarios with heavy oversight. As the market evaluates the opportunities available, several tech and biotech companies are already moving toward

    7/29/25 3:01:00 PM ET
    $GEHC
    $HCTI
    $MDAI
    Medical Electronics
    Health Care
    EDP Services
    Technology

    Spartan Capital Securities, LLC Announces Key February Transactions

    New York, NY, March 07, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a full-service investment banking firm, is pleased to announce a series of strategic transactions completed in February 2025, reinforcing its position as a trusted financial partner for companies across diverse industries. Spartan Capital successfully served as the sole placement agent for Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) in a $3.788 million private placement. This financing represents an important milestone in Lipella's efforts to advance its clinical pipeline and address significant unmet medical needs under the leadership of CEO Dr. Jonathan Kaufman. The firm also played a key role as Co-Place

    3/7/25 4:56:47 PM ET
    $HCTI
    $LIPO
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Spartan Capital Securities, LLC Serves as Co-Placement Agent in Healthcare Triangle, Inc.'s $15.2 Million Private Placement

    New York, NY, March 04, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of a $15.2 million private placement for Healthcare Triangle, Inc. (NASDAQ:HCTI). Spartan Capital Securities, LLC acted as Co-Placement Agent in this private offering, supporting Healthcare Triangle's continued expansion and digital transformation initiatives in the healthcare and life sciences industries. The proceeds from this offering will fund strategic acquisitions, general corporate purposes, and working capital needs, further advancing Healthcare Triangle's mission to deliver cutting-edge cloud enablement, cybersecuri

    3/4/25 8:55:00 AM ET
    $HCTI
    EDP Services
    Technology

    $HCTI
    Leadership Updates

    Live Leadership Updates

    View All

    Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO

    PLEASANTON, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc. (NASDAQ:HCTI) ("Healthcare Triangle," "HCTI" or the "Company"), a frontrunner in healthcare technology has announced the appointment of Anand Kumar as the interim Chief Executive Officer alongside his current role as the Chief Revenue Officer. Anand is committed to leading the Company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, Artificial Intelligence (AI) and Large Language Models (LLM). With a wealth of experience and a track record of successfully leading initiatives, Anand is strategically positioned to guide HCTI through its next phase of

    3/12/24 9:41:00 AM ET
    $HCTI
    EDP Services
    Technology

    $HCTI
    Financials

    Live finance-specific insights

    View All

    Healthcare Triangle, Inc. Releases Shareholder Update

    Highlights Market Opportunity and Recent Accretive Acquisition Awarded Top 100 Premier Partner Status at Amazon World Services & Premier Partner Status at Google Cloud PLEASANTON, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (NASDAQ:HCTI) ("HCTI" or the "Company") a leading provider of cloud and data transformation platform and solutions for healthcare and life sciences, today released a shareholder update: Dear Shareholders: Thank you for your continued commitment and investment in Healthcare Triangle, Inc . Our progress over the past year would not have been possible without your trust and belief in our mission. This is our first shareholder update since our

    1/20/22 8:30:00 AM ET
    $HCTI
    EDP Services
    Technology

    Healthcare Triangle (HCTI) Acquires DevCool, an Electronic Health Record (EHR) Focused Healthcare IT and Managed Services Company

    PLEASANTON, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (HCTI), a leading provider of Healthcare and Life Sciences cloud transformation, managed services and data analytics platform company, announced today that it has acquired DevCool, Inc. ("DevCool"), ranked by Inc. 5000 as among the fastest growing private companies in USA in 2021. DevCool provides EHR Implementation and Managed Services to 6 of the top 10 hospitals in the USA and specializes in providing services to cancer research hospitals and university medical centres. The combined entity will focus on accelerating healthcare providers to adopt cloud technologies in improving clinical, operational, and fin

    12/13/21 8:00:00 AM ET
    $HCTI
    EDP Services
    Technology

    $HCTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Healthcare Triangle Inc. (Amendment)

    SC 13D/A - Healthcare Triangle, Inc. (0001839285) (Subject)

    10/26/21 4:00:01 PM ET
    $HCTI
    EDP Services
    Technology

    SEC Form SC 13D filed by Healthcare Triangle Inc.

    SC 13D - Healthcare Triangle, Inc. (0001839285) (Subject)

    10/25/21 5:27:12 PM ET
    $HCTI
    EDP Services
    Technology